7 Deaths Linked to EpiPen Failures

Failures of the potentially life-saving auto-injector EpiPen (epinephrine), used when someone has a severe allergic reaction, to work properly have led to 7 deaths so far this year, according to data from the FDA.

Bloomberg News reports that through mid-September of this year, there were 228 reports of an EpiPen failing to deploy properly. In 2012, there were only 4 reports of such failures. The 228 failures so far this year also led to 35 hospitalizations.

Bloomberg also reported that an inspection of a facility that produced the pens found evidence that epinephrine leaked out of some of them and in other cases, the auto-injector device didn’t work properly. The FDA, however, says it is unaware of any defective EpiPens on the market.

Mylan, EpiPen’s manufacturer, came under fire last year after it raised the price of EpiPen from $50 for a single auto-injector to $600 for a two-pack.


Jonathan Block

Jonathan Block

Jonathan Block is a freelance writer and former MedShadow content editor. He has been an editor and writer for multiple pharmaceutical, health and medical publications, including BioCentury, The Pink Sheet, Modern Healthcare, Health Plan Week and Psychiatry Advisor. He holds a BA from Tufts University and is earning an MPH with a focus on health policy from the CUNY Graduate School of Public Health & Health Policy.


Did you find this article helpful?


Latest News

Synthetic Red Blood Cells, NOAC’s for Atrial Fibrillation, Surgery to Ease Sciatica Pain

Synthetic Red Blood Cells, NOAC’s for Atrial Fibrillation, Surgery to Ease Sciatica Pain

Researchers have managed to create artificial red blood cells that can transport medication. Compared to the popular anticoagulant Warfarin, NOAC’s may be superior for treating atrial fibrillation patients with prior intracranial hemorrhage. Also, surgery may be the preferred choice for reducing leg pain in patients with sciatica.  Synthetic Red Blood…

FDA Recalls Metformin and NP Thyroid

FDA Recalls Metformin and NP Thyroid

The FDA has issued a recall of two drugs–NP Thyroid and Metformin–after testing revealed that they weren’t up to code. Read more below, and if you’re taking either medication, please be sure to contact your doctor for how to continue treatment responsibly.  NP Thyroid Recalled Thirteen lots of NP Thyroid,…

  • Advertisement